GI Dynamics enrolls first patient in pivotal EndoBarrier trial

Minimally-Invasive, Innovative Therapy Used for Treating Type 2 Diabetes and Obesity U-M expert discusses an upcoming clinical trial involving a new non-invasive, endoscopic weight-loss procedure called the EndoBarrier®.

GI Dynamics continues to turn its story around with UK study.

The EndoBarrier Device for Type 2 Diabetes: What You Need to Know

EndoBarrier – What is the EndoBarrier?

New Devices to Combat Obesity, from Three Boston-Area Firms

GI Dynamics wins FDA nod for pivotal US EndoBarrier trial

Efforts are being made to kick-start further development of a duodenal-jejunal bypass liner, the EndoBarrier (GI Dynamics), this time specifically for use in obese patients with type 2 diabetes, after some issues with the device in earlier trials.

New EndoBarrier tech looks set to rival traditional gastric bypass surgery.

The Guardian reports: “Device that helps obese diabetic lose weight ‘should be rolled out across NHS’”